(PharmaNewsWire.Com, September 15, 2017 ) The Global Anatomy Pathology Market was worth USD 16.2 billion in 2016 and is estimated to be growing at a CAGR of 6.1%, to reach USD 21.78 billion by 2021.
The market is showcasing evident potential in the mentioned forecasting period. As the times have changed, people have become more conscious about their health. Anatomy Pathology has played a vital role in study, diagnosis and treatment of these diseases. The overall market for anatomic pathology is increasing considerably because of the rising use and viability of biomarkers in diagnosing different infection including cancer.
Anatomy Pathology features the diagnosis of disease based on the macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues. The data generated by Anatomy Pathology is further analysed and is used by doctors for a better health management. Anatomy Pathology is basically one of the branches of the pathology stream, other being the Clinical Pathology.
With the enormous number of ongoing developments and innovations in the healthcare and electronics sector, rising spending capabilities and the ease of use of medical devices the rising incidences of chronic diseases amongst all demographics; market is growing at a huge rate. This market is facing challenges mainly competing with the Physician Groups, like speciality physicians merging or adding ancillary services and large commercial labs. There is a constant significant reimbursement pressure. These factors may act as growth hurdles for the Anatomy Pathology Market in certain regions.
Market Segmentation
• Product o Instruments o Accessories o Y-o-Y Growth Analysis, By Product o Market Attractiveness Analysis, By Product o Market Share Analysis, By Product
• End-User o Diagnostics Lab o Hospitals o Physicians' Office Lab o Y-o-Y Growth Analysis, By End-User o Market Attractiveness Analysis, By Type o Market Share Analysis, By End-User
• Application o Lymphoma o Breast o Lung o Cervical o Colorectal o Prostate o Y-o-Y Growth Analysis, By Application o Market Attractiveness Analysis, By Application o Market Share Analysis, By Application
On the basis of geography, the global market is analysed under various regions namely North America, Europe, Asia-Pacific and Rest of the World. The Anatomy Pathology market was dominated by North America, with the overall market share of over 44.8% globally in 2016. North America was followed by Europe and Asia-Pacific. Asia Pacific is predicted to grow at a rapid pace in the coming few years.
Some of the major companies dominating the market, by their products and services include Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche AG (Switzerland), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan).
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
